127 related articles for article (PubMed ID: 11221862)
1. PAX3 is expressed in human melanomas and contributes to tumor cell survival.
Scholl FA; Kamarashev J; Murmann OV; Geertsen R; Dummer R; Schäfer BW
Cancer Res; 2001 Feb; 61(3):823-6. PubMed ID: 11221862
[TBL] [Abstract][Full Text] [Related]
2. Expression of genes for microphthalmia isoforms, Pax3 and MSG1, in human melanomas.
Vachtenheim J; Novotná H
Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):1075-82. PubMed ID: 10644012
[TBL] [Abstract][Full Text] [Related]
3. Detection of PAX3-FKHR and PAX7-FKHR fusion transcripts in rhabdomyosarcoma by reverse transcriptase-polymerase chain reaction using paraffin-embedded tissue.
Chen BF; Chen ML; Liang DC; Huang YW; Liu HC; Chen SH
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Feb; 62(2):86-91. PubMed ID: 10063718
[TBL] [Abstract][Full Text] [Related]
4. Transfection of melanoma cells with antisense PAX3 oligonucleotides additively complements cisplatin-induced cytotoxicity.
He SJ; Stevens G; Braithwaite AW; Eccles MR
Mol Cancer Ther; 2005 Jun; 4(6):996-1003. PubMed ID: 15956257
[TBL] [Abstract][Full Text] [Related]
5. Predominant expression of alternative PAX3 and PAX7 forms in myogenic and neural tumor cell lines.
Barr FG; Fitzgerald JC; Ginsberg JP; Vanella ML; Davis RJ; Bennicelli JL
Cancer Res; 1999 Nov; 59(21):5443-8. PubMed ID: 10554014
[TBL] [Abstract][Full Text] [Related]
6. Expression of PAX 3 alternatively spliced transcripts and identification of two new isoforms in human tumors of neural crest origin.
Parker CJ; Shawcross SG; Li H; Wang QY; Herrington CS; Kumar S; MacKie RM; Prime W; Rennie IG; Sisley K; Kumar P
Int J Cancer; 2004 Jan; 108(2):314-20. PubMed ID: 14639621
[TBL] [Abstract][Full Text] [Related]
7. PAX3 expression in normal skin melanocytes and melanocytic lesions (naevi and melanomas).
Medic S; Ziman M
PLoS One; 2010 Apr; 5(4):e9977. PubMed ID: 20421967
[TBL] [Abstract][Full Text] [Related]
8. Aberrant PAX3 and PAX7 expression. A link to the metastatic potential of embryonal rhabdomyosarcoma and cutaneous malignant melanoma?
Blake J; Ziman MR
Histol Histopathol; 2003 Apr; 18(2):529-39. PubMed ID: 12647804
[TBL] [Abstract][Full Text] [Related]
9. Expression of PAX3 in Ewing's sarcoma family of tumors.
Schulte TW; Toretsky JA; Ress E; Helman L; Neckers LM
Biochem Mol Med; 1997 Apr; 60(2):121-6. PubMed ID: 9169092
[TBL] [Abstract][Full Text] [Related]
10. Temporally regulated neural crest transcription factors distinguish neuroectodermal tumors of varying malignancy and differentiation.
Gershon TR; Oppenheimer O; Chin SS; Gerald WL
Neoplasia; 2005 Jun; 7(6):575-84. PubMed ID: 16036108
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of melanoma inhibitory activity (MIA) expression in melanoma cells leads to molecular and phenotypic changes.
Tatzel J; Poser I; Schroeder J; Bosserhoff AK
Pigment Cell Res; 2005 Apr; 18(2):92-101. PubMed ID: 15760338
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor II and PAX3-FKHR cooperate in the oncogenesis of rhabdomyosarcoma.
Wang W; Kumar P; Wang W; Epstein J; Helman L; Moore JV; Kumar S
Cancer Res; 1998 Oct; 58(19):4426-33. PubMed ID: 9766674
[TBL] [Abstract][Full Text] [Related]
13. The alveolar rhabdomyosarcoma PAX3/FKHR fusion protein is a transcriptional activator.
Sublett JE; Jeon IS; Shapiro DN
Oncogene; 1995 Aug; 11(3):545-52. PubMed ID: 7630639
[TBL] [Abstract][Full Text] [Related]
14. PAX3 expression in primary melanomas and nevi.
Plummer RS; Shea CR; Nelson M; Powell SK; Freeman DM; Dan CP; Lang D
Mod Pathol; 2008 May; 21(5):525-30. PubMed ID: 18327212
[TBL] [Abstract][Full Text] [Related]
15. PAX3 across the spectrum: from melanoblast to melanoma.
Medic S; Ziman M
Crit Rev Biochem Mol Biol; 2009 Jun; 44(2-3):85-97. PubMed ID: 19401874
[TBL] [Abstract][Full Text] [Related]
16. Differential PAX3 functions in normal skin melanocytes and melanoma cells.
Medic S; Rizos H; Ziman M
Biochem Biophys Res Commun; 2011 Aug; 411(4):832-7. PubMed ID: 21802410
[TBL] [Abstract][Full Text] [Related]
17. FOXD3 Promotes PAX3 Expression in Melanoma Cells.
Kubic JD; Little EC; Kaiser RS; Young KP; Lang D
J Cell Biochem; 2016 Feb; 117(2):533-41. PubMed ID: 26252164
[TBL] [Abstract][Full Text] [Related]
18. Pax3 and regulation of the melanocyte-specific tyrosinase-related protein-1 promoter.
Galibert MD; Yavuzer U; Dexter TJ; Goding CR
J Biol Chem; 1999 Sep; 274(38):26894-900. PubMed ID: 10480898
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms contributing to differential regulation of PAX3 downstream target genes in normal human epidermal melanocytes versus melanoma cells.
Bartlett D; Boyle GM; Ziman M; Medic S
PLoS One; 2015; 10(4):e0124154. PubMed ID: 25880082
[TBL] [Abstract][Full Text] [Related]
20. Pax3 transcripts in melanoblast development.
Blake JA; Ziman MR
Dev Growth Differ; 2005 Dec; 47(9):627-35. PubMed ID: 16316407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]